Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLI with Chemotherapy in Older Patients with High-Risk AML or MDS
NCT02046122Phase 2Completed
- Sponsor
- Duke University
- Start
- Jul 2014
- Primary completion
- Jun 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donor lymphocyte infusion in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Duke University. Started Jul 2014; status: completed.
02
Drugs
donor lymphocyte infusion
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02046122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046122.